Taishi Yonezawa to CRISPR-Cas Systems
This is a "connection" page, showing publications Taishi Yonezawa has written about CRISPR-Cas Systems.
Connection Strength
0.061
-
Opposing effects of acute versus chronic inhibition of p53 on decitabine's efficacy in myeloid neoplasms. Sci Rep. 2019 06 03; 9(1):8171.
Score: 0.031
-
Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis. Nat Commun. 2018 07 16; 9(1):2733.
Score: 0.029